CRIS Current Research Information System

RE, MARIA CARLA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 10.307
EU - Europa 8.470
AS - Asia 8.273
AF - Africa 587
SA - Sud America 475
OC - Oceania 21
Continente sconosciuto - Info sul continente non disponibili 7
AN - Antartide 1
Totale 28.141
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 10.183
SG - Singapore 2.381
VN - Vietnam 2.302
CN - Cina 1.882
IT - Italia 1.533
DE - Germania 1.336
GB - Regno Unito 1.285
NL - Olanda 1.263
SE - Svezia 1.082
HK - Hong Kong 587
FR - Francia 458
IN - India 426
RU - Federazione Russa 345
BR - Brasile 319
IE - Irlanda 274
UA - Ucraina 261
TG - Togo 184
JP - Giappone 126
ZA - Sudafrica 123
FI - Finlandia 101
CI - Costa d'Avorio 99
BG - Bulgaria 86
JO - Giordania 86
EE - Estonia 85
CA - Canada 72
NG - Nigeria 69
AR - Argentina 67
PH - Filippine 64
BE - Belgio 57
KR - Corea 57
ID - Indonesia 54
AT - Austria 53
SC - Seychelles 48
TH - Thailandia 46
CH - Svizzera 43
PL - Polonia 40
BD - Bangladesh 38
TR - Turchia 35
HR - Croazia 29
ES - Italia 28
MX - Messico 25
IQ - Iraq 22
EC - Ecuador 21
PK - Pakistan 21
PT - Portogallo 21
SA - Arabia Saudita 20
TW - Taiwan 20
CL - Cile 19
IR - Iran 19
UZ - Uzbekistan 18
LT - Lituania 17
AU - Australia 16
CO - Colombia 16
MY - Malesia 16
RO - Romania 16
LB - Libano 13
EG - Egitto 12
CZ - Repubblica Ceca 9
ET - Etiopia 9
GR - Grecia 9
PY - Paraguay 9
RS - Serbia 8
VE - Venezuela 8
IL - Israele 7
KZ - Kazakistan 7
HN - Honduras 6
LY - Libia 6
PE - Perù 6
DK - Danimarca 5
DZ - Algeria 5
MD - Moldavia 5
NP - Nepal 5
BO - Bolivia 4
CY - Cipro 4
EU - Europa 4
HU - Ungheria 4
KE - Kenya 4
MA - Marocco 4
NZ - Nuova Zelanda 4
PA - Panama 4
A2 - ???statistics.table.value.countryCode.A2??? 3
BB - Barbados 3
CG - Congo 3
MK - Macedonia 3
SI - Slovenia 3
TN - Tunisia 3
UY - Uruguay 3
AE - Emirati Arabi Uniti 2
AL - Albania 2
AZ - Azerbaigian 2
BA - Bosnia-Erzegovina 2
BH - Bahrain 2
BS - Bahamas 2
CM - Camerun 2
DO - Repubblica Dominicana 2
GE - Georgia 2
LV - Lettonia 2
MG - Madagascar 2
SK - Slovacchia (Repubblica Slovacca) 2
TT - Trinidad e Tobago 2
Totale 28.102
Salva come PNG Salva come JPEG
Città #
Singapore 1.666
Ashburn 1.091
Southend 1.082
Fairfield 909
Chandler 736
Kerkrade 648
San Jose 611
Hong Kong 541
Frankfurt am Main 524
Ann Arbor 497
Santa Clara 497
Ho Chi Minh City 473
Hanoi 437
Woodbridge 433
Seattle 423
Houston 415
Dong Ket 410
Wilmington 373
Eygelshoven 338
Princeton 337
Cambridge 328
Beijing 284
Dublin 274
Bologna 261
Boardman 213
Lomé 184
Lauterbourg 166
Jacksonville 147
Los Angeles 130
Westminster 130
Nanjing 129
Berlin 110
Tokyo 105
Hefei 102
Abidjan 99
Milan 98
Padova 94
New York 92
Turin 91
Amman 85
Redmond 84
Sofia 82
Dallas 80
Council Bluffs 72
Florence 69
Buffalo 68
Des Moines 68
San Diego 68
Helsinki 67
Jinan 67
Redondo Beach 65
Abeokuta 63
Haiphong 62
Da Nang 60
Shenyang 60
Brussels 54
Munich 53
Saint Petersburg 53
Bremen 51
Rome 49
Guangzhou 48
Shanghai 48
Hebei 46
Chicago 45
Phoenix 45
Tianjin 42
São Paulo 39
Seoul 38
Nanchang 35
Changsha 34
London 34
Nuremberg 34
Mülheim 31
Vienna 31
Zhengzhou 30
Dearborn 29
Falls Church 29
Hangzhou 29
Jakarta 29
Olalla 29
Bern 28
Redwood City 28
Orem 27
Paris 26
Warsaw 26
Falkenstein 25
Montreal 24
Thái Nguyên 24
Atlanta 23
Ningbo 23
Verona 23
Yubileyny 23
Toronto 22
Amsterdam 21
Biên Hòa 20
The Dalles 20
Bühl 19
Can Tho 19
Jiaxing 19
Monmouth Junction 19
Totale 18.042
Salva come PNG Salva come JPEG
Nome #
18F-FDG PET/CT in visceral leishmaniasis: uptake patterns in the context of a multiannual outbreak in Northern Italy 1.731
ALTERAZIONI DEL MICROBIOMA FARINGEO IN CORSO DI INFEZIONI DA NEISSERIA GONORRHOEAE 345
Analisi della trasmissione di SARS-CoV-2: influenza delle condizioni termoigrometriche rispetto al rischio di diffusione del contagio 336
QuantiFERON-TB Gold Plus with Chemiluminescence Immunoassay: Do We Need a Higher Cutoff? 330
RILEVAZIONE DELLA STRUTTURA MOSAICO DEL GENE PENA IN SEDE ORO-FARINGEA 279
Restriction Factors expression decreases in HIV-1 patients after cART 272
IFI16 reduced expression is correlated with unfavorable outcome in chronic lymphocytic leukemia 267
Pharyngeal Chlamydia and gonorrhea: a hidden problem 248
Serum antibodies against human intracisternal A-type particle (HIAP) endogenous retrovirus in Alopecia areata patients: a hallmark of autoimmune disease? 247
Impact of meropenem on Klebsiella pneumoniae metabolism 246
Quantitative detection of human immunodeficiency virus type 1 (HIV-1) proviral DNA in peripheral blood mononuclear cells by SYBR green real-time PCR technique. 238
Acute onset myopericarditis as unusual presentation of primary HIV infection 238
Analysis of the effects of HIV-1 Tat on the survival and differentiation of vessel wall-derived mesenchymal stem cells 237
Comparison of the Aptima HIV-1 Quant Dx Assay with the COBAS® AmpliPrep/COBAS® TaqMan® HIV-1 v2.0 Test for HIV-1 Viral Load Quantification in Plasma Samples from HIV-1-Infected Patients. 237
Mosaic structure of the penA gene in the oropharynx of men who have sex with men negative for gonorrhoea 236
Discordant resistance interpretations in multi-treated HIV-1 patients 235
Development of C-TILDA: A modified TILDA method for reservoir quantification in long term treated patients infected with subtype C HIV-1 233
IFI16 expression is related to selected transcription factors during B-cell differentiation 229
Conflicting interpretations of the prevalence of mutations associated with drug resistance in antiviral naive HIV-1 patients with acute and chronic infection 226
Pre-Pregnancy Diet and Vaginal Environment in Caucasian Pregnant Women: An Exploratory Study 226
Serum antibody reactivity to human intracisternal A-type particle retrovirus proteins in systemic sclerosis patients 214
Low-dose doxycycline induces Chlamydia trachomatis persistence in HeLa cells 210
Autochthonous cases of mucosal leishmaniasis in Northeastern Italy: clinical management and novel treatment approaches 209
Significant Decrease in Plasma Levels of D-Dimer, Interleukin-8, and Interleukin-12 After a 12-Month Treatment with Rosuvastatin in HIV-Infected Patients Under Antiretroviral Therapy 208
HIV-1 DNA proviral load in treated and untreated HIV-1 seropositive patients. 204
Improvement of Mycobacterium tuberculosis detection by Xpert MTB/RIF Ultra: A head-to-head comparison on Xpert-negative samples 204
Calcaneal quantitative ultrasound (QUS) and dual X-ray absorptiometry (DXA) bone analysis in adult HIV-positive patients. 201
Pattern of arterial inflammation and inflammatory markers in people living with HIV compared with uninfected people 200
HIV-1 and recombinant gp120 affect the survival and differentiation of human vessel wall-derived mesenchymal stem cells 197
Pharyngeal microbiome alterations during Neisseria gonorrhoeae infection 197
Encephalopathy in COVID-19 Presenting With Acute Aphasia Mimicking Stroke 196
Dual raltegravir-darunavir/ritonavir combination in virologically suppressed HIV-1-infected patients on antiretroviral therapy including a ritonavir-boosted protease inhibitor plus two nucleoside/nucleotide reverse transcriptase inhibitors 193
Asymptomatic Leishmania infantum infection in blood donors living in an endemic area, northeastern Italy 193
Monitoring the treatment of hepatitis C with directly acting antivirals by serological and molecular methods 193
Effects of Antiretroviral Molecules on Survival and Gene Expression of an Osteoblast-like Cell Line 192
Impact of different antiretroviral strategies on total HIV-DNA level in virologically suppressed HIV-1 infected patients. 191
SARS-CoV-2/COVID-19 testing: The tower of babel 191
Peptide-derivatized SB105-A10 dendrimer inhibits the infectivity of R5 and X4 HIV-1 strains in primary PBMCs and cervicovaginal histocultures. 190
Clinical application of Bruker Biotyper MALDI-TOF/MS system for real-time identification of KPC production in Klebsiella pneumoniae clinical isolates 189
Subgingival periodontal pathogens in Down syndrome children without periodontal breakdown. A case-control study on deciduous teeth 189
Antiretroviral molecules and cardiovascular diseases. 188
Prevalence of R5 strains in multi-treated HIV subjects and impact of new regimens including maraviroc in a selected group of patients with CCR5-tropic HIV-1 infection. 185
Pharyngeal chlamydia and gonorrhoea: a hidden problem. 185
M48U1 and Tenofovir combination synergistically inhibits HIV infection in activated PBMCs and human cervicovaginal histocultures 185
Analysis of the effects of specific protease inhibitors on OPG/RANKL regulation in an osteoblast-like cell line. 183
Validation of a Cleanroom Compliant Sonication-Based Decellularization Technique: A New Concept in Nerve Allograft Production 182
HIV-1 DNA load analysis in peripheral blood lymphocytes and monocytes from naïve and HAART-treated individuals. 182
HIV-1 early and late diagnosis in the Emilia Romagna Region (Italy): A three year study 181
Serum hepatitis B core-related antigen is an effective tool to categorize patients with HBeAg-negative chronic hepatitis B 181
Incomplete IgG response to HIV-1 proteins and low avidity levels in recently converted HIV patients treated with early antiretroviral therapy. 181
Detection of serum antibodies to human intracisternal A-type retroviral particles in chronic idiopathic urticaria 180
Bloodstream infection caused by KPC-producing Klebsiella pneumoniae resistant to ceftazidime/avibactam: epidemiology and genomic characterization 180
Recent and long-lasting infections: the need for avidity testing in HIV-1 infected subjects. 178
Comparison of MycoPrep and the new MYCO-TB kit: rapid and efficient digestion and decontamination of respiratory specimens for the detection of Mycobacteria 177
Antiviral activity of interferon-based combination therapy in critically ill patients with COVID-19: Preliminary observations 177
Prevalence of hypovitaminosis D and factors associated with vitamin D deficiency and morbidity among HIV-infected patients enrolled in a large Italian cohort. 176
High-throughput genotyping of high-risk Human Papillomavirus by MALDI-TOF Mass Spectrometry-based method. 176
Children and SARS-CoV-2 infection: innocent bystanders…until proven otherwise 174
Different patterns of HIV-1 DNA after therapy discontinuation 173
Quantitative DNA proviral detection in HIV-1 patients treated with antiretroviral therapy. 173
Rectal Microbiota Associated With Chlamydia trachomatis and Neisseria gonorrhoeae Infections in Men Having Sex With Other Men 172
HIV and kidney: A dangerous liaison 171
Host restriction factors and Human immunodeficiency Virus (HIV-1): a dynamic interplay involving all phases of the viral life cycle 171
Changes in Serum Markers of Inflammation and Endothelial Activation in HIV-Infected Antiretroviral Naive Patients Starting A Treatment with Abacavir-Lamivudine or Tenofovir-Emtricitabine Plus Efavirenz 171
HIV-1 Tat protein concomitantly down-regulates apical caspase-10 and up-regulates c-FLIP in lymphoid T cells: A potential molecular mechanism to escape TRAIL cytotoxicity 171
Factors associated with vitamin D deficiency in HIV-1 infected patients on combination antiretroviral therapy: a case-control study. 171
Effects of human immunodeficiency virus on the erythrocyte and megakaryocyte lineages. 170
Genotypic resistance in plasma and peripheral blood lymphocytes in a group of naive HIV-1 patients. 170
Cap. 4- IL MICROBIOMA OCULARE E IMPATTO SUL SISTEMA IMMUNE 170
Total integration of cultural and molecular testing for CPE screening with liquid based microbiology (LBM) 170
Prospective evaluation of bone markers, parathormone and 1,25-(OH)₂ vitamin D in HIV-positive patients after the initiation of tenofovir/emtricitabine with atazanavir/ritonavir or efavirenz 169
Molecular Bases of Osteoporosis in HIV: The Role of the Virus and Antiretroviral Therapy 169
No correlation between statin exposure and incident diabetes mellitus in HIV-1-infected patients receiving combination antiretroviral therapy 169
A large outbreak of giardiasis in a municipality of the Bologna province, north-eastern Italy, november 2018 to april 2019 168
HIV-1 and HCV detection in dried blood spots by SYBR Green multiplex real-time RT-PCR. 166
HIV-1 infection of a nurse from a newborn with an unknown HIV infection: a case report. 166
HIV-1 coreceptor usage in paired plasma RNA and proviral DNA from patients with acute and chronic infection never treated with antiretroviral therapy 165
Bone alterations during HIV infection 165
Comparative serum bactericidal activity of meropenem-based combination regimens against extended-spectrum beta-lactamase and KPC-producing Klebsiella pneumoniae 165
Low avidity antibody: a reliable method to diagnose a recent HIV-1 infection. 164
HIV-related mechanisms in atherosclerosis and cardiovascular diseases. 164
Human T-lymphotropic virus type 1 (HTLV-1) prevalence and quantitative detection of DNA proviral load in individuals with indeterminate/positive serological results 162
Prevalence of antiretroviral drug resistance in untreated persons newly diagnosed with HIV-1 infection 162
Predictors of time to sputum smear conversion in patients with pulmonary tuberculosis under treatment 162
Guidelines for the qualitative detection of viral genomes in dried blood spots. 160
Improvement in insulin sensitivity and serum leptin concentration after the switch from a ritonavir-boosted PI to raltegravir or dolutegravir in non-diabetic HIV-infected patients 160
Nevirapine prophylaxis to prevent HIV-1 mother-to-child transmission: pharmacokinetic considerations in preterm infants 159
Screening strategies for the diagnosis of asymptomatic Leishmania infection in dialysis patients as a model for kidney transplant candidates 159
HIV-1 subtype C transmission network: The phylogenetic reconstruction strongly supports the epidemiological data. 159
Evaluation of HIV-DNA and inflammatory markers in HIV-infected individuals with different viral load patterns 158
Potential role of T2Candida in the management of empirical antifungal treatment in patients at high risk of candidaemia: a pilot single-centre study 158
In vitro interaction of ceftazidime–avibactam in combination with different antimicrobials against KPC-producing Klebsiella pneumoniae clinical isolates 157
HIV-1 gp120 impairs the differentiation and survival of cord blood CD34+ HPCs induced to the erythroid lineage. 155
Durable viral suppression in an HIV-infected patient in the absence of antiretroviral therapy 154
The Gut Microbiota of Critically Ill Patients With COVID-19 154
Molecular and phylogenetic analysis of HIV-1 variants circulating in Italy. 152
A novel IncA plasmid carrying blaVIM-1 in a Kluyvera cryocrescens strain 152
Two cases of relapsed HIV-associated visceral leishmaniasis successfully treated with combination therapy 152
Carbapenemase-producing Enterobacterales: changing epidemiology in a highly endemic Italian area 152
An imported case of adult T cell leukemia in a HTLV-I-infected patient in Italy. 151
Totale 20.709
Salva come PNG Salva come JPEG
Categoria #
all - tutte 74.710
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 74.710
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021892 0 0 0 0 0 0 0 0 0 0 127 765
2021/20223.542 245 194 205 414 295 188 73 228 132 463 630 475
2022/20233.753 398 525 219 508 286 241 106 219 617 136 321 177
2023/20241.065 74 166 83 119 89 219 70 71 22 71 40 41
2024/20253.874 163 607 312 289 665 223 235 132 64 339 151 694
2025/20269.373 721 653 607 590 1.000 1.521 1.274 409 1.817 648 133 0
Totale 28.698